Literature DB >> 32070145

Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer.

Tianyi Gao1, Xiangxiang Liu2, Bangshun He2, Yuqin Pan2, Shukui Wang1.   

Abstract

91H, a long non-coding antisense transcripts located on the position of the H19/IGF2 locus had been suggested to play a critical role in tumour development. However, little study had proved the mechanism in colorectal cancer (CRC). Hence, we performed this study to deeply explore the mechanism of lncRNA 91H in tumour progression. The expression of lncRNA 91H was first detected in CRC tissues and cells which was higher in vitro and in vivo than normal cells or tissues and CRC patients with high lncRNA 91H expression usually had a high risk in tumour metastasis (p < .05). Then, monodansylcadaverine (MDC) staining, scratch wound, migration and invasion assays were conducted which showed to that reduced lncRNA 91H would greatly affect tumour migration, invasion and autophagy. Finally, by RNA pull down and RNA-binding protein immunoprecipitation (RIP) assay, a significant interaction was found between lncRNA 91H and IGF2BP2 which was proved to play an important role in CRC IGF2 expression. All these results suggested lncRNA 91H promotes IGF2 expression by interacting with IGF2BP2 which would provide a new strategy in finding potential CRC diagnostic biomarkers and therapeutic targets.

Entities:  

Keywords:  CRC; IGF2; IGF2BP2; lncRNA 91H

Mesh:

Substances:

Year:  2020        PMID: 32070145     DOI: 10.1080/21691401.2020.1727491

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  13 in total

Review 1.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

Review 2.  The Role of Autophagy in Childhood Central Nervous System Tumors.

Authors:  Yafeng Wang; Yiran Xu; Changlian Zhu
Journal:  Curr Treat Options Oncol       Date:  2022-10-05

3.  Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.

Authors:  Jing Ji; Chen Li; Jinfeng Wang; Lei Wang; Huifang Huang; Ying Li; Jing Fang
Journal:  Cell Cycle       Date:  2022-02-03       Impact factor: 5.173

4.  Knockdown of 91 H Suppresses the Tumorigenesis of Osteosarcoma via Inducing Methylation of CDK4 Promoter.

Authors:  Suoli Cheng; Jianping Zheng; Xueqin Liu; Jiandang Shi; Fan Gong; Xu Zhang; Changhao Liu; Cuiyun Liu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 5.  Novel Regulators of the IGF System in Cancer.

Authors:  Caterina Mancarella; Andrea Morrione; Katia Scotlandi
Journal:  Biomolecules       Date:  2021-02-12

6.  lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1.

Authors:  Jie Gu; Bo Dai; Xuchao Shi; Zhennian He; Yuanlin Xu; Xiangqian Meng; Junlan Zhu
Journal:  Aging (Albany NY)       Date:  2021-09-13       Impact factor: 5.682

7.  Circ_0026579 alleviates LPS-induced WI-38 cells inflammation injury in infantile pneumonia.

Authors:  Yang Yu; Tingting Yang; Zhaozheng Ding; Yuan Cao
Journal:  Innate Immun       Date:  2022-01       Impact factor: 2.680

8.  Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease.

Authors:  Denisse Sepúlveda; Felipe Grunenwald; Alvaro Vidal; Paulina Troncoso-Escudero; Marisol Cisternas-Olmedo; Roque Villagra; Pedro Vergara; Carlos Aguilera; Melissa Nassif; Rene L Vidal
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

Review 9.  The biological function of IGF2BPs and their role in tumorigenesis.

Authors:  Qiu-Ying Du; Zhi-Man Zhu; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-12       Impact factor: 3.850

10.  Autophagy-related long non-coding RNA signature for ovarian cancer.

Authors:  Chan Meng; Jie-Qiong Zhou; Yong-Sheng Liao
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.